<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Clearbridge Large Cap Growth Esg Etf — News on 6ix</title>
<link>https://6ix.com/company/clearbridge-large-cap-growth-esg-etf</link>
<description>Latest news and press releases for Clearbridge Large Cap Growth Esg Etf on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Thu, 02 Apr 2026 04:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/clearbridge-large-cap-growth-esg-etf" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835938478dffbe2df10358c.webp</url>
<title>Clearbridge Large Cap Growth Esg Etf</title>
<link>https://6ix.com/company/clearbridge-large-cap-growth-esg-etf</link>
</image>
<item>
<title>Freshworks Expands IT Asset Management Capabilities by Adding Continuous Infrastructure Discovery and Dependency Mapping to Freshservice</title>
<link>https://6ix.com/company/clearbridge-large-cap-growth-esg-etf/news/freshworks-expands-it-asset-management-capabilities-by-adding-continuous-infrastructure-discovery-and-dependency-mapping-to-freshservice-42</link>
<guid isPermaLink="true">https://6ix.com/company/clearbridge-large-cap-growth-esg-etf/news/freshworks-expands-it-asset-management-capabilities-by-adding-continuous-infrastructure-discovery-and-dependency-mapping-to-freshservice-42</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>New ITAM product provides visibility into how infrastructure supports the services that businesses depends onSAN MATEO, Calif., April 02, 2026 (GLOBE</description>
</item>
<item>
<title>Academy Sports + Outdoors Announces Participation in Upcoming Investor Conference</title>
<link>https://6ix.com/company/clearbridge-large-cap-growth-esg-etf/news/academy-sports-outdoors-announces-participation-in-upcoming-investor-conference-43</link>
<guid isPermaLink="true">https://6ix.com/company/clearbridge-large-cap-growth-esg-etf/news/academy-sports-outdoors-announces-participation-in-upcoming-investor-conference-43</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>KATY, Texas, April 2, 2026 /PRNewswire/ -- Academy Sports + Outdoors ("Academy" or the "Company") (Nasdaq: ASO), a leading full-line sporting goods and</description>
</item>
<item>
<title>Nanox Signs Distribution Agreement with Integrity Medical Service, Inc. to Deploy Nanox.ARC Systems</title>
<link>https://6ix.com/company/clearbridge-large-cap-growth-esg-etf/news/nanox-signs-distribution-agreement-with-integrity-medical-service-inc-to-deploy-nanoxarc-systems-17</link>
<guid isPermaLink="true">https://6ix.com/company/clearbridge-large-cap-growth-esg-etf/news/nanox-signs-distribution-agreement-with-integrity-medical-service-inc-to-deploy-nanoxarc-systems-17</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>New regional partnership strengthens Nanox’s presence and service support across outpatient imaging settings in Colorado, Wyoming and the western parts of</description>
</item>
<item>
<title>Catheter Precision Engages Strategic Advisor</title>
<link>https://6ix.com/company/clearbridge-large-cap-growth-esg-etf/news/catheter-precision-engages-strategic-advisor-38</link>
<guid isPermaLink="true">https://6ix.com/company/clearbridge-large-cap-growth-esg-etf/news/catheter-precision-engages-strategic-advisor-38</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>Goal to unlock value in cardiac electrophysiology assets Strategic process to include outreach to leading global medical device companies FORT MILL, S.C.,</description>
</item>
<item>
<title>Xeriant Receives U.S. Patent Notice Allowance for its Breakthrough Fire-Resistant Composite Technology</title>
<link>https://6ix.com/company/clearbridge-large-cap-growth-esg-etf/news/xeriant-receives-us-patent-notice-allowance-for-its-breakthrough-fire-resistant-composite-technology-39</link>
<guid isPermaLink="true">https://6ix.com/company/clearbridge-large-cap-growth-esg-etf/news/xeriant-receives-us-patent-notice-allowance-for-its-breakthrough-fire-resistant-composite-technology-39</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>Positions the Company at the forefront of next-generation building materials BOCA RATON, Fla., April 02, 2026 (GLOBE NEWSWIRE) -- Xeriant, Inc. (OTCQB: XERI),</description>
</item>
<item>
<title>TransUnion Introduces TruIQ Credit Strategy Studio to Transform How Lenders Build and Launch Prescreen Marketing Campaigns</title>
<link>https://6ix.com/company/clearbridge-large-cap-growth-esg-etf/news/transunion-introduces-truiq-credit-strategy-studio-to-transform-how-lenders-build-and-launch-prescreen-marketing-campaigns-21</link>
<guid isPermaLink="true">https://6ix.com/company/clearbridge-large-cap-growth-esg-etf/news/transunion-introduces-truiq-credit-strategy-studio-to-transform-how-lenders-build-and-launch-prescreen-marketing-campaigns-21</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>New solution can reduce prescreen build times by up to 75% CHICAGO, April 02, 2026 (GLOBE NEWSWIRE) -- With consumer credit originations expected to rise in</description>
</item>
<item>
<title>Lipocine Reports Topline Safety and Efficacy Results for LPCN 1154 in Patients with Postpartum Depression</title>
<link>https://6ix.com/company/clearbridge-large-cap-growth-esg-etf/news/lipocine-reports-topline-safety-and-efficacy-results-for-lpcn-1154-in-patients-with-postpartum-depression-37</link>
<guid isPermaLink="true">https://6ix.com/company/clearbridge-large-cap-growth-esg-etf/news/lipocine-reports-topline-safety-and-efficacy-results-for-lpcn-1154-in-patients-with-postpartum-depression-37</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>In the Phase 3 study population (N=90) of patients with PPD, LPCN 1154 did not show a statistically significant reduction from baseline in HAM-D17 total score</description>
</item>
<item>
<title>Everus Acquires SE&M, Leading Contractor in Southeast Region</title>
<link>https://6ix.com/company/clearbridge-large-cap-growth-esg-etf/news/everus-acquires-seandm-leading-contractor-in-southeast-region</link>
<guid isPermaLink="true">https://6ix.com/company/clearbridge-large-cap-growth-esg-etf/news/everus-acquires-seandm-leading-contractor-in-southeast-region</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>Further Diversifies Revenue Mix With Leading Position in Industrial, Pharmaceutical End Markets Expands Mechanical Services Offering in Attractive Southeast</description>
</item>
<item>
<title>Guidefitter Deepens Strategic Partnership with Rocky Brands, Inc., Expands Platform to Include Muck and XTRATUF</title>
<link>https://6ix.com/company/clearbridge-large-cap-growth-esg-etf/news/guidefitter-deepens-strategic-partnership-with-rocky-brands-inc-expands-platform-to-include-muck-and-xtratuf-15</link>
<guid isPermaLink="true">https://6ix.com/company/clearbridge-large-cap-growth-esg-etf/news/guidefitter-deepens-strategic-partnership-with-rocky-brands-inc-expands-platform-to-include-muck-and-xtratuf-15</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>Expansion Builds on Longstanding Collaboration with Rocky Boots, Bringing Additional Rocky Brands Portfolio Leaders into Guidefitter's Professional</description>
</item>
<item>
<title>Lantern Pharma Invites Investors, Analysts & Shareholders to Experience the Future of Drug Discovery via a Live Demo of withZeta.ai — the World's First Multi-Agentic Co-Scientist for Rare Cancers — 8:30 AM Eastern, April 9, 2026</title>
<link>https://6ix.com/company/clearbridge-large-cap-growth-esg-etf/news/lantern-pharma-invites-investors-analysts-and-shareholders-to-experience-the-future-of-drug-discovery-via-a-live-demo-of-withzetaai-the-worlds-first-multi-agentic-co-scientist-for-rare-cancers-830-am-eastern-april-9-2026-23</link>
<guid isPermaLink="true">https://6ix.com/company/clearbridge-large-cap-growth-esg-etf/news/lantern-pharma-invites-investors-analysts-and-shareholders-to-experience-the-future-of-drug-discovery-via-a-live-demo-of-withzetaai-the-worlds-first-multi-agentic-co-scientist-for-rare-cancers-830-am-eastern-april-9-2026-23</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>Briefing to Feature a Live Walkthrough, Demonstration of Key Features, The Market Opportunity & Industry Need, Competitive Positioning, and Platform</description>
</item>
<item>
<title>European Wax Center's EWC TREAT® Dual-Sided Dry Brush Wins 2026 NewBeauty Award</title>
<link>https://6ix.com/company/clearbridge-large-cap-growth-esg-etf/news/european-wax-centers-ewc-treatr-dual-sided-dry-brush-wins-2026-newbeauty-award-33</link>
<guid isPermaLink="true">https://6ix.com/company/clearbridge-large-cap-growth-esg-etf/news/european-wax-centers-ewc-treatr-dual-sided-dry-brush-wins-2026-newbeauty-award-33</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>PLANO, Texas, April 2, 2026 /PRNewswire/ -- European Wax Center, Inc. (NASDAQ: EWCZ), the leading franchisor and operator of out-of-home waxing services, is</description>
</item>
<item>
<title>Letter to Shareholders from Marcus Lemonis, Executive Chairman and CEO: The Growth Phase</title>
<link>https://6ix.com/company/clearbridge-large-cap-growth-esg-etf/news/letter-to-shareholders-from-marcus-lemonis-executive-chairman-and-ceo-the-growth-phase-48</link>
<guid isPermaLink="true">https://6ix.com/company/clearbridge-large-cap-growth-esg-etf/news/letter-to-shareholders-from-marcus-lemonis-executive-chairman-and-ceo-the-growth-phase-48</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>MURRAY, Utah--(BUSINESS WIRE)-- Bed Bath & Beyond, Inc. (NYSE: BBBY) (“Bed Bath & Beyond” or “BBBY”) has issued the following letter from Marcus Lemonis,</description>
</item>
<item>
<title>FOREX Goes Live with Diebold Nixdorf's Branch Automation Solutions for End-to-End ATM Management</title>
<link>https://6ix.com/company/clearbridge-large-cap-growth-esg-etf/news/forex-goes-live-with-diebold-nixdorfs-branch-automation-solutions-for-end-to-end-atm-management-26</link>
<guid isPermaLink="true">https://6ix.com/company/clearbridge-large-cap-growth-esg-etf/news/forex-goes-live-with-diebold-nixdorfs-branch-automation-solutions-for-end-to-end-atm-management-26</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>The solution gives financial institutions a single trusted partner to run their entire ATM channel — securely, efficiently and at optimized cost. NORTH</description>
</item>
<item>
<title>MDIC appoints Philips Chief Medical Officer Carla Goulart Peron as new board member</title>
<link>https://6ix.com/company/clearbridge-large-cap-growth-esg-etf/news/mdic-appoints-philips-chief-medical-officer-carla-goulart-peron-as-new-board-member-7</link>
<guid isPermaLink="true">https://6ix.com/company/clearbridge-large-cap-growth-esg-etf/news/mdic-appoints-philips-chief-medical-officer-carla-goulart-peron-as-new-board-member-7</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>April 2, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that Carla Goulart</description>
</item>
<item>
<title>Dr. Calvin Choi, Founder of AMTD IDEA, Re‑Appointed as the Chief President of the Hong Kong Island Youth United Association</title>
<link>https://6ix.com/company/clearbridge-large-cap-growth-esg-etf/news/dr-calvin-choi-founder-of-amtd-idea-reappointed-as-the-chief-president-of-the-hong-kong-island-youth-united-association-1</link>
<guid isPermaLink="true">https://6ix.com/company/clearbridge-large-cap-growth-esg-etf/news/dr-calvin-choi-founder-of-amtd-idea-reappointed-as-the-chief-president-of-the-hong-kong-island-youth-united-association-1</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>PARIS and NEW YORK and LONDON, April 2, 2026 /PRNewswire/ -- AMTD Group Inc. ("AMTD Group"), AMTD IDEA Group (NYSE: AMTD; SGX: HKB), AMTD Digital Inc. (NYSE:</description>
</item>
<item>
<title>Curanex Expands Its Drug Development Pipeline to Include Cancer Cachexia, Representing a Multi-Billion-Dollar Market Opportunity and Important Step In The Company’s Evolution Into a Broader Therapeutics Development Company</title>
<link>https://6ix.com/company/clearbridge-large-cap-growth-esg-etf/news/curanex-expands-its-drug-development-pipeline-to-include-cancer-cachexia-representing-a-multi-billion-dollar-market-opportunity-and-important-step-in-the-companys-evolution-into-a-broader-therapeutics-development-company-30</link>
<guid isPermaLink="true">https://6ix.com/company/clearbridge-large-cap-growth-esg-etf/news/curanex-expands-its-drug-development-pipeline-to-include-cancer-cachexia-representing-a-multi-billion-dollar-market-opportunity-and-important-step-in-the-companys-evolution-into-a-broader-therapeutics-development-company-30</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>Company expands strategic focus into one of oncology’s most urgent supportive-care challenges Jericho, New York, April 02, 2026 (GLOBE NEWSWIRE) -- Curanex</description>
</item>
<item>
<title>PureTech Announces Publication of Phase 2b ELEVATE IPF Trial Results in The American Journal of Respiratory and Critical Care Medicine</title>
<link>https://6ix.com/company/clearbridge-large-cap-growth-esg-etf/news/puretech-announces-publication-of-phase-2b-elevate-ipf-trial-results-in-the-american-journal-of-respiratory-and-critical-care-medicine-4</link>
<guid isPermaLink="true">https://6ix.com/company/clearbridge-large-cap-growth-esg-etf/news/puretech-announces-publication-of-phase-2b-elevate-ipf-trial-results-in-the-american-journal-of-respiratory-and-critical-care-medicine-4</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>Deupirfenidone 825 mg TID monotherapy significantly slowed lung function decline versus placebo at 26 weeks in people with idiopathic pulmonary fibrosis</description>
</item>
<item>
<title>IFF Launches PureStrong™, a Probiotic Made Specifically for Dogs</title>
<link>https://6ix.com/company/clearbridge-large-cap-growth-esg-etf/news/iff-launches-purestrongtm-a-probiotic-made-specifically-for-dogs-6</link>
<guid isPermaLink="true">https://6ix.com/company/clearbridge-large-cap-growth-esg-etf/news/iff-launches-purestrongtm-a-probiotic-made-specifically-for-dogs-6</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>NEW YORK--(BUSINESS WIRE)-- IFF (NYSE: IFF)—a global leader in flavors, fragrances, food ingredients and health & biosciences—is introducing PureStrong™, a</description>
</item>
<item>
<title>Valley National Bank Celebrates Opening of Melbourne Branch, Strengthening Central Florida Relationships</title>
<link>https://6ix.com/company/clearbridge-large-cap-growth-esg-etf/news/valley-national-bank-celebrates-opening-of-melbourne-branch-strengthening-central-florida-relationships-13</link>
<guid isPermaLink="true">https://6ix.com/company/clearbridge-large-cap-growth-esg-etf/news/valley-national-bank-celebrates-opening-of-melbourne-branch-strengthening-central-florida-relationships-13</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>New location provides relationship-focused banking services for commercial and consumer clients MELBOURNE, Fla.--(BUSINESS WIRE)-- Valley National Bank, a</description>
</item>
<item>
<title>PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio</title>
<link>https://6ix.com/company/clearbridge-large-cap-growth-esg-etf/news/pavmed-appoints-joseph-virgilio-to-lead-relaunched-medical-device-portfolio-34</link>
<guid isPermaLink="true">https://6ix.com/company/clearbridge-large-cap-growth-esg-etf/news/pavmed-appoints-joseph-virgilio-to-lead-relaunched-medical-device-portfolio-34</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>Medtech industry veteran to oversee development and commercialization of PAVmed's current and future medical device portfolio.Octeris, Inc. subsidiary formed</description>
</item>
</channel>
</rss>